The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-((3-Phenyl-6-(trifluoromethyl)-1H-indazol-1-yl)methyl)thiazole-4-carboxylic acid ID: ALA4129545
PubChem CID: 59179974
Max Phase: Preclinical
Molecular Formula: C19H12F3N3O2S
Molecular Weight: 403.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1csc(Cn2nc(-c3ccccc3)c3ccc(C(F)(F)F)cc32)n1
Standard InChI: InChI=1S/C19H12F3N3O2S/c20-19(21,22)12-6-7-13-15(8-12)25(9-16-23-14(10-28-16)18(26)27)24-17(13)11-4-2-1-3-5-11/h1-8,10H,9H2,(H,26,27)
Standard InChI Key: HKAVNJPOQSRMTB-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
3.6966 -12.4848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6954 -13.3044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4035 -13.7133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4017 -12.0760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1103 -12.4812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1106 -13.2999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8892 -13.5526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3703 -12.8901 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8888 -12.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1394 -11.4523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9401 -11.2832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1924 -10.5068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6452 -9.8987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8423 -10.0724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5937 -10.8486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1461 -14.3318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9461 -14.4983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2851 -15.2418 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.0974 -15.1529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2640 -14.3528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5545 -13.9474 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9685 -13.9377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6798 -14.3399 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9612 -13.1205 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9874 -13.7124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2800 -13.3032 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.9868 -14.5296 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.2741 -14.1151 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
9 10 1 0
7 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 17 2 0
20 22 1 0
22 23 2 0
22 24 1 0
2 25 1 0
25 26 1 0
25 27 1 0
25 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 403.39Molecular Weight (Monoisotopic): 403.0602AlogP: 4.93#Rotatable Bonds: 4Polar Surface Area: 68.01Molecular Species: ACIDHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.18CX Basic pKa: 1.05CX LogP: 4.83CX LogD: 1.38Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -1.56
References 1. Atobe M, Naganuma K, Kawanishi M, Hayashi T, Suzuki H, Nishida M, Arai H.. (2018) Discovery of a novel 2-(1H-pyrazolo[3,4-b]pyridin-1-yl)thiazole derivative as an EP1 receptor antagonist and in vivo studies in a bone fracture model., 28 (14): [PMID:29934246 ] [10.1016/j.bmcl.2018.06.022 ]